Notably, as also reported in multiple myeloma and CLL [38,39], VEN sensitivity is strongly and inversely correlated with the BCL-2/MCL-1 ratio, with a loss of AML cell sensitivity when high levels of MCL-1 are expressed [18,40,41,42,43]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.